v3.26.1
Document And Entity Information - shares
 9 Months Ended
Dec. 31, 2025
Feb. 06, 2026
Document Information [Line Items]    
Document Type 10-Q/A  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2025  
Document Transition Report false  
Entity File Number 001-38426  
Entity Registrant Name SENMIAO TECHNOLOGY LIMITED  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 35-2600898  
Entity Address, Address Line One 16F, Shihao Square  
Entity Address, Address Line Two Middle Jiannan Blvd  
Entity Address, Address Line Three High-Tech Zone Chengdu  
Entity Address, City or Town Sichuan  
Entity Address, Country CN  
Entity Address, Postal Zip Code 610000  
City Area Code +86 28  
Local Phone Number 61554399  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol AIHS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,557,489
Amendment Flag true  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --03-31  
Amendment Description References throughout this Amendment No. 1 to the Quarterly Report on Form 10-Q to “we,” “us,” the “Company”, the “Group” or “our company” are to Senmiao Technology Limited, unless the context otherwise indicates.The Company is filing this Amendment No. 1 (“Amendment No. 1”) to the Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2025, originally filed with the Securities and Exchange Commission (“SEC”) on February 13, 2026 (the “Original Filing”) to restate its unaudited condensed consolidated financial statements as of and for the three and nine months ended December 31, 2025.As previously announced in our Current Report on Form 8-K filed with the SEC on June 30, 2026, during the preparation of the Company’s consolidated financial statements for the year ended March 31, 2026, the Company’s management identified the following misstatements, to the Company’s unaudited condensed financial statements as of and for the three and nine months ended December 31, 2025:During the three and nine months ended December 31, 2025, pre-funded warrants and November 2025 private placement warrants issued with common stocks in November 2025 were incorrectly classified as equity instruments, while the pre-funded warrants and November 2025 private placement warrants should be classified as liability instruments measured at fair value, with changes in fair value reported each period in earnings. Such error has resulted in the misstatements of “derivative liabilities”, “additional paid-in capital” and “accumulated deficit” as of December 31, 2025, and the misstatements of “change in fair value of derivative liabilities”, “excess of warrant fair value over offering proceeds”, “other income, net”, “net loss from continuing operations”, and “net loss” for the three and nine months ended December 31, 2025. Adjustments have been made to the statements of operations as well as the balance sheet, statement of changes in equity (deficit) and statement of cash flows. The amount recorded reflects pre-funded warrants and November 2025 private placement warrants as liability instruments measured at fair value and resulted in increase in other expense, increase in derivative liabilities, and a reduction to additional paid-in capital.Therefore, on June 26, 2026, the audit committee of the board of directors of the Company, after discussion with the Company’s management, concluded that the Company’s unaudited condensed consolidated financial statements as of and for the three and nine months ended December 31, 2025 included in the Quarterly Report on Form 10-Q as filed with the SEC on February 13, 2026 (the “Q3 10-Q”), should no longer be relied upon due to the misstatements described above.As such, the Company is filing Amendment No. 1 to the Q3 10-Q to restate its unaudited condensed consolidated financial statements as of and for the three and nine months ended December 31, 2025.After re-evaluation, the Company’s management has concluded that the errors arose due to its previously reported material weaknesses in the Company’s internal control over financial reporting relating to ineffective controls over period end financial disclosure and reporting processes. The Company did not have sufficient personnel with appropriate levels of accounting knowledge and experience to address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP. Specifically, the Company’s control did not operate effectively to ensure the appropriate and timely analysis of and accounting for unusual and non-routine transactions and certain financial statement accounts. The Company’s remediation plan with respect to such material weakness is described in more detail in Item 4 of Part I to this Quarterly Report on Form 10-Q/A.The changes to the Q3 10-Q are those related to the matters described above. Except as described above, this Amendment does not amend, update or change any other item or disclosure in the Q3 10-Q and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Q3 10-Q was filed, and we have not undertaken to amend, update or change any information contained in the Q3 10-Q to give effect to any subsequent event, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Q3 10-Q.  
Entity Central Index Key 0001711012